Objective. To study the effect of sepsis on circulating neutrophils in
very low birth weight neonates and to assess the usefulness of recent
ly revised reference ranges for circulating neutrophils in the diagnos
is of sepsis in this population by comparison with previously reported
reference ranges. Methods. Neutrophil parameters (absolute total neut
rophils, absolute total immature neutrophils, and the immature:total n
eutrophil proportion) were analyzed retrospectively in 202 sepsis epis
odes in 192 neonates (birth weight = 1055 +/- 246 g, X +/- SD; estimat
ed gestational age = 29 +/- 2 weeks) between birth and 30 days of age.
The percentage of values lying outside the reference ranges reported
recently by Mouzinho et al(32) and previously by Manroe et al(24) were
compared. To more accurately assess possible differences in specifici
ty between the two reference ranges, neonates with early-onset group B
streptococcal infection (n = 19) were compared with a matched control
group (n = 51) using conditional logistic regression. Results. Greate
r sensitivity was observed using the previous reference ranges of Manr
oe et al(24) over the entire study period (0 to 720 hours) both for th
e initial and the second complete blood count (CBC). The previous refe
rence ranges also were more sensitive than the revised ranges for the
initial CBC at 0 to 72 and at 73 to 720 hours and for infections attri
butable to coagulase-negative staphylococci. However, specificity in n
eonates without group B streptococcal infection was significantly grea
ter with the revised reference ranges compared with those of Manroe et
al(24) (initial CBC, 73% vs 45%; serial CBCs, 59% vs 10%). Conclusion
. The observed differences in sensitivities may be of limited clinical
significance because very low birth weight infants often are begun on
antibiotic therapy regardless of laboratory values. However, the stri
king differences in specificity using the revised reference ranges sug
gest that these ranges may be clinically useful in determining length
of antimicrobial therapy in infants in whom cultures remain sterile.